| 标题 |
A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx® in Healthy Chinese Male Subjects |
| 网址 | |
| DOI | |
| 其它 |
期刊:Drug Design, Development and Therapy 作者:Feng Yao; Chenguang Wang; Jie Ding; Qian Zhang; Liang Zheng; et al 出版日期:2024-08-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)